Advanced Estrogen Receptor Positive HER2- Breast Cancer
1 clinical trials · Condition
◉ Watch Advanced Estrogen Receptor Positive HER2- Breast Cancer
| Record | Firm | Date |
|---|---|---|
| GS-5829 in Combination With Fulvestrant or Exemestane in Women With Advanced Estrogen Receptor Positive, HER2 Negative-Breast Cancer (NCT02983604) | Gilead Sciences | 2017-01-10 |
Track Advanced Estrogen Receptor Positive HER2- Breast Cancer automatically
Every clearance here is in the API, with alerts when new ones post.